BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 15610315)

  • 1. Infrequency of colonization with Oxalobacter formigenes in inflammatory bowel disease: possible role in renal stone formation.
    Kumar R; Ghoshal UC; Singh G; Mittal RD
    J Gastroenterol Hepatol; 2004 Dec; 19(12):1403-9. PubMed ID: 15610315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal colonization with Oxalobacter formigenes and its relation to urinary oxalate excretion in pediatric patients with idiopathic calcium urolithiasis.
    Sikora P; Niedźwiadek J; Mazur E; Paluch-Oleś J; Zajaczkowska M; Kozioł-Montewka M
    Arch Med Res; 2009 Jul; 40(5):369-73. PubMed ID: 19766900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis.
    Hoppe B; von Unruh GE; Blank G; Rietschel E; Sidhu H; Laube N; Hesse A
    Am J Kidney Dis; 2005 Sep; 46(3):440-5. PubMed ID: 16129205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate.
    Troxel SA; Sidhu H; Kaul P; Low RK
    J Endourol; 2003 Apr; 17(3):173-6. PubMed ID: 12803990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy.
    Sidhu H; Schmidt ME; Cornelius JG; Thamilselvan S; Khan SR; Hesse A; Peck AB
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S334-40. PubMed ID: 10541258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical analysis of the role of gut Oxalobacter formigenes in oxalate stone disease.
    Siva S; Barrack ER; Reddy GP; Thamilselvan V; Thamilselvan S; Menon M; Bhandari M
    BJU Int; 2009 Jan; 103(1):18-21. PubMed ID: 19021605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperoxaluria, hypocitraturia, hypomagnesiuria, and lack of intestinal colonization by Oxalobacter formigenes in a cervical spinal cord injury patient with suprapubic cystostomy, short bowel, and nephrolithiasis.
    Vaidyanathan S; von Unruh GE; Watson ID; Laube N; Willets S; Soni BL
    ScientificWorldJournal; 2006 Apr; 6():2403-10. PubMed ID: 17619709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stone composition, metabolic profile and the presence of the gut-inhabiting bacterium Oxalobacter formigenes as risk factors for renal stone formation.
    Mittal RD; Kumar R; Mittal B; Prasad R; Bhandari M
    Med Princ Pract; 2003; 12(4):208-13. PubMed ID: 12966191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria.
    Hoppe B; Groothoff JW; Hulton SA; Cochat P; Niaudet P; Kemper MJ; Deschênes G; Unwin R; Milliner D
    Nephrol Dial Transplant; 2011 Nov; 26(11):3609-15. PubMed ID: 21460356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal stone formation in patients with inflammatory bowel disease.
    Caudarella R; Rizzoli E; Pironi L; Malavolta N; Martelli G; Poggioli G; Gozzetti G; Miglioli M
    Scanning Microsc; 1993 Mar; 7(1):371-9; discussion 379-80. PubMed ID: 8316806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antibiotics on Oxalobacter formigenes colonization of human gastrointestinal tract.
    Mittal RD; Kumar R; Bid HK; Mittal B
    J Endourol; 2005; 19(1):102-6. PubMed ID: 15735393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Oxalobacter formigenes in calcium oxalate stone disease: a study from North India.
    Kumar R; Mukherjee M; Bhandari M; Kumar A; Sidhu H; Mittal RD
    Eur Urol; 2002 Mar; 41(3):318-22. PubMed ID: 12180235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of intestinal oxalate-degrading bacteria with recurrent calcium kidney stone formation and hyperoxaluria: a case-control study.
    Tavasoli S; Alebouyeh M; Naji M; Shakiba Majd G; Shabani Nashtaei M; Broumandnia N; Basiri A
    BJU Int; 2020 Jan; 125(1):133-143. PubMed ID: 31145528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Oxalobacter formigenes colonization in calcium oxalate stone disease.
    Siener R; Bangen U; Sidhu H; Hönow R; von Unruh G; Hesse A
    Kidney Int; 2013 Jun; 83(6):1144-9. PubMed ID: 23536130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxalobacter colonization in the morbidly obese and correlation with urinary stone risk.
    Duffey BG; Miyaoka R; Holmes R; Assimos D; Hinck B; Korman E; Kieley F; Ikramuddin S; Kellogg T; Moeding A; Monga M
    Urology; 2011 Sep; 78(3):531-4. PubMed ID: 21529902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of colonization with real-time PCR to identify the role of Oxalobacter formigenes in calcium oxalate urolithiasis.
    Batislam E; Yilmaz E; Yuvanc E; Kisa O; Kisa U
    Urol Res; 2012 Oct; 40(5):455-60. PubMed ID: 22215293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability of Oxalobacter formigenes and oxalate in stool samples.
    Prokopovich S; Knight J; Assimos DG; Holmes RP
    J Urol; 2007 Nov; 178(5):2186-90. PubMed ID: 17870112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of Oxalobacter formigenes in cystic fibrosis patients: a risk factor for hyperoxaluria.
    Sidhu H; Hoppe B; Hesse A; Tenbrock K; Brömme S; Rietschel E; Peck AB
    Lancet; 1998 Sep; 352(9133):1026-9. PubMed ID: 9759746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithogenic risk factors for renal stones in patients with Crohn's disease.
    Buño Soto A; Torres Jiménez R; Olveira A; Fernández-Blanco Herraiz I; Montero García A; Mateos Antón F
    Arch Esp Urol; 2001 Apr; 54(3):282-92. PubMed ID: 11432047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease.
    Winterkamp S; Weidenhiller M; Otte P; Stolper J; Schwab D; Hahn EG; Raithel M
    Am J Gastroenterol; 2002 Dec; 97(12):3071-7. PubMed ID: 12492192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.